Login to Your Account

Financings Roundup

GlobeImmune Files IPO to Raise $69M for Tarmogens

By Catherine Shaffer
Staff Writer

Thursday, July 5, 2012
GlobeImmune Inc. filed for a $69 million initial public offering (IPO) to advance its cancer and infectious disease products developed using the Tarmogen platform.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription